ClinicalTrials.gg

Program

TAK-951

A development code.

Its studies are mostly in Nausea · Postoperative Nausea and Vomiting, led by Takeda.

Furthest: phase 2, since Sep 18, 20205 company-led studies, 0 open or running

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Takeda50 open or runningphase 2since Sep 18, 2020Jul 22, 2020none ahead

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Jul 22, 2020First study: phase 1 study in Healthy VolunteerFirst studyNCT04486950 · 32 enrolled · United States
  2. Sep 18, 2020Phase 2 study in Postoperative Nausea and VomitingNCT04557189 · 89 enrolled · United States
  3. Oct 25, 2021Phase 1 study in Healthy VolunteersNCT05567393 · 128 enrolled · United States
  4. Sep 21, 2024Phase 1 study in Healthy VolunteersNCT06610279 · 48 enrolled · United States
  5. Jan 6, 2025Phase 1 study in NauseaNCT06768658 · 1 enrolled · United States

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 5 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT06768658Nausea · United States1TerminatedJan 9, 20231
NCT06610279Healthy Volunteers · United States1TerminatedSep 21, 202348
NCT05567393Healthy Volunteers · United States1CompletedNov 2, 2020128
NCT04557189Postoperative Nausea and Vomiting · United States2CompletedMar 7, 202289
NCT04486950Healthy Volunteer · United States1CompletedMay 16, 202132

How it is read

Names in the registry

  • “TAK-951”, 5 entries

Codes read as this program: TAK951.

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.